tirzepatide and psoriatic arthritis Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with in comorbid overweight or obese adults with showed clinically meaningful improvement of psoriatic disease, physical function, weight Big news from the research
Description
16 Combining therapies with complementary but distinct mechanisms of action may lead to greater weight loss and improvements in associated risk factors compared with individual medications
2021;75(9):e14060
This prevents the stacking effect when you start the new medication
Our practice recognizes the importance of a tailored approach to weight management
We placed the cage on a glass plate above the plantar test apparatus, positioning a movable noxious heat source directly beneath the hindpaws plantar surface
Because of this, Tirzepatide might be more effective for weight management than the usual one-hormone treatments
